SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-24-000013
Filing Date
2024-02-02
Accepted
2024-02-02 08:51:10
Documents
29
Period of Report
2024-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K angn-20240201.htm   iXBRL 8-K 31703
2 EX-10.1+ elicio-executiveseveranc.htm EX-10.1+ 56961
6 elicio-executiveseveranc001.jpg GRAPHIC 268408
7 elicio-executiveseveranc002.jpg GRAPHIC 285708
8 elicio-executiveseveranc003.jpg GRAPHIC 226948
9 elicio-executiveseveranc004.jpg GRAPHIC 275561
10 elicio-executiveseveranc005.jpg GRAPHIC 283899
11 elicio-executiveseveranc006.jpg GRAPHIC 293099
12 elicio-executiveseveranc007.jpg GRAPHIC 293722
13 elicio-executiveseveranc008.jpg GRAPHIC 330010
14 elicio-executiveseveranc009.jpg GRAPHIC 255158
15 elicio-executiveseveranc010.jpg GRAPHIC 253863
16 elicio-executiveseveranc011.jpg GRAPHIC 288489
17 elicio-executiveseveranc012.jpg GRAPHIC 298485
18 elicio-executiveseveranc013.jpg GRAPHIC 171791
19 elicio-executiveseveranc014.jpg GRAPHIC 45615
  Complete submission text file 0001601485-24-000013.txt   5161708

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20240201.xsd EX-101.SCH 1989
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20240201_lab.xml EX-101.LAB 25138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20240201_pre.xml EX-101.PRE 13130
31 EXTRACTED XBRL INSTANCE DOCUMENT angn-20240201_htm.xml XML 2816
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 24588914
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)